Charlotte Delaunay-Laniece

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

COVID-19 Vaccine Effectiveness Among Older Adults.

COVID-19 Vaccine Effectiveness Among Older Adults.

Journal: JAMA network open
Published: June 15, 2026

The effect of SARS-CoV-2 testing on healthcare-seeking behaviour at primary care level.

The effect of SARS-CoV-2 testing on healthcare-seeking behaviour at primary care level.

Journal: International journal of epidemiology
Published: April 02, 2025

COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.

COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.

Journal: Influenza and other respiratory viruses
Published: March 10, 2025

The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population.

The potential bias introduced into COVID-19 vaccine effectiveness studies at primary care level due to the availability of SARS-CoV-2 tests in the general population.

Journal: International journal of epidemiology
Published: November 25, 2024

Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)].

Corrigendum to "Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023-January 2024" [Vaccine 42(19) (2024)].

Journal: Vaccine
Published: July 06, 2024

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 Among Older Europeans.

Journal: JAMA network open
Published: July 01, 2024

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.

Journal: Influenza and other respiratory viruses
Published: June 21, 2024

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
Published: March 29, 2024

Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.

Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.

Journal: Vaccine
Published: March 22, 2024

Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.

Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.

Journal: The International journal on drug policy
Published: October 26, 2022

The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.

The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination.

Journal: The International journal on drug policy
Published: October 05, 2022

Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?

Impacts of the COVID-19 pandemic on hepatitis C elimination in Canada: Where do we go from here?

Journal: Canadian liver journal
Published: August 18, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026